NCT03222167 Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b Status UNKNOWN Phase PHASE3
NCT03221634 Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668) Status WITHDRAWN Phase PHASE2
NCT03221426 Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) Status COMPLETED Phase PHASE3
NCT03220477 Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03219450 A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. Status RECRUITING Phase PHASE1
NCT03217565 A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014) Status COMPLETED Phase PHASE1
NCT03217136 MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035) Status COMPLETED Phase PHASE2
NCT03217071 Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT03216525 Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol Status RECRUITING Phase PHASE3
NCT03213730 Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery Status COMPLETED Phase NA
NCT03213041 Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT03212651 Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab Status COMPLETED Phase PHASE2
NCT03211416 Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03201744 Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair Status WITHDRAWN Phase NA
NCT03200847 Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT03198559 Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART Status TERMINATED Phase PHASE1/PHASE2